Epigenetic modulator LSD1, a theragnostic target for potentially malignant oral disorders and malignant lesions

Click to increase image sizeClick to decrease image size

VP Jayaseelan: conceptualization, manuscript writing; P Arumugam: manuscript writing, supervision.

Financial & competing interests disclosure

The authors thank the Science and Engineering Research Board, government of India, for the financial support rendered through the core research grant (no. CRG/2019/003756). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.